share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股sec公告 ·  06/14 16:33
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $139,081.62, were acquired on 06/13/2023 through a stock option exercise, with the securities originally issued by the issuer. The transaction is part of a pre-planned trading activity that was adopted on 03/01/2023. This sale follows a series of transactions over the past three months where a total of 63,124 shares were sold by the officer.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $139,081.62, were acquired on 06/13/2023 through a stock option exercise, with the securities originally issued by the issuer. The transaction is part of a pre-planned trading activity that was adopted on 03/01/2023. This sale follows a series of transactions over the past three months where a total of 63,124 shares were sold by the officer.
Recursion Pharmaceuticals公司的高管Secora Michael计划于2024年06月14日以每股总市值为139,081.62美元的价格卖出15,000股A类股票,该股票是通过股票期权行权于2023年06月13日获得,最初由发行人发行。该交易是在2023年03月01日采取的预定交易活动的一部分。此次出售是在过去三个月内进行的一系列交易之后,该高管总共出售了63,124股。
Recursion Pharmaceuticals公司的高管Secora Michael计划于2024年06月14日以每股总市值为139,081.62美元的价格卖出15,000股A类股票,该股票是通过股票期权行权于2023年06月13日获得,最初由发行人发行。该交易是在2023年03月01日采取的预定交易活动的一部分。此次出售是在过去三个月内进行的一系列交易之后,该高管总共出售了63,124股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息